why choose us

Clinical Trials Search

Showing 6,520 of 132,085 result(s)
A Study of LY3305677 Compared With Placebo in Adult Participants With Obesity or Overweight

Status: COMPLETED

Condition: Obesity

Interventions: Administered SC

Date: 2023-11-06

Study Evaluating Treatment of Sacituzumab-govitecan for Patients With Metastatic Esophagogastric Adenocarcinoma

Status: COMPLETED

Condition: Esophagogastric Adenocarcinoma

Interventions: 10 mg;kg i.v. at day 1 and day 8 of each 21-day cycle (Q3W) for max 17 cycles (max.
12 months treatment)

Date: 2023-11-06

Electromuscular Stimulation Therapy as a Prophylactic Method to Reduce Thromboses Related to PICC Catheters

Status: COMPLETED

Condition: Thrombosis; Catheter, Infusion Catheter (Vascular)

Interventions: DEVICE: Protocol ECOEMS - Use electo estimulation therapy. The 4-channel stimulator will be used. The 6 electrodes will be located on the biceps, tric

Date: 2023-11-06

Effectiveness of Iso-inertial Resistance Training in Physically Active Older Adults

Status: Completed

Condition: Aged

Interventions: For the front lunge and the front lunge with hand grip pull, the participant will be placed frontally on the training device (inertial).
Whereas

Date: 2023-11-06

Efficacy of Manual Therapy Based on the Fascial Distortion Model in Individuals With Temporomandibular Disorder

Status: Completed

Condition: Temporomandibular Disorder

Interventions: The following techniques were used on the cranial and cervical areas during therapy: Trigger band technique, herniated trigger point technique, contin

Date: 2023-11-06

Reduction of Microemboli of Air Using a New Developed Air Trap (EmbolessTM) During Haemodialysis

Status: Completed

Condition: Hemodialysis Complication

Interventions: Emboless has the US patent number 8894749 is compared to standard dialysis See also reference Jonsson et al 2023 referred to in the main text.

Date: 2023-11-06

The Efficacy and Safety of Protoxin in Subjects With Moderate to Severe Glabellar Lines

Status: COMPLETED

Condition: Glabellar Frown Lines

Interventions: Clostridium botulinum toxin type A

Date: 2023-11-06

A Study of Subcutaneous Gefurulimab Using Prefilled Syringe Versus Autoinjector in Healthy Adult Participants

Status: COMPLETED

Condition: Healthy Adult Participants

Interventions: Participants will receive a single 600 mg dose of Gefurulimab PFS-SD subcutaneously (SC) on Day 1.

Date: 2023-11-06

An Observational Study to Describe EVUSHELD™ (Tixagevimab;Cilgavimab) Pre-exposure Prophylaxis in Real-world Setting in Japan

Status: COMPLETED

Condition: COVID-19

Interventions: Administration of Evusheld 600 mg

Date: 2023-11-06

A Study to Identify Barriers to Cellular Therapies for People With Plasma Cell Disorders

Status: Completed

Condition: Multiple Myeloma

Interventions: Physician investigators will review a lecture on the role of cellular therapies in relapse;refractory multiple myeloma;RRMM that discusses c

Date: 2023-11-06